Time-Restricted Eating for Cancer-Related Fatigue
Trial Summary
What is the purpose of this trial?
This study will assess the feasibility of delivering a 12-week time-restricted eating intervention as well as the intervention's preliminary efficacy on persistent cancer-related fatigue among cancer survivors compared to a general health education control. Participants will be randomized 1:1 to one of two arms: time-restricted eating or control. Those in the intervention arm will self-select a 10-hour eating window in which to consume all food and beverages (water is allowed any time, black coffee and unsweetened tea are allowed in the morning). Both groups will receive weekly educational tips on healthy lifestyle behaviors in cancer survivorship. This study will also explore relationships between fatigue, circadian rhythm, and glucose metabolism. The hypothesis is that recruitment will be feasible, and participants will adhere to time-restricted eating and complete study activities over the course of the 12 weeks. The second hypothesis is that time-restricted eating will lead to less fatigue at 12 weeks compared to the control, accounting for baseline fatigue levels.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking insulin or have any contraindications to the nutrition intervention, you may not be eligible to participate.
What data supports the effectiveness of the treatment Time-Restricted Eating for Cancer-Related Fatigue?
Is time-restricted eating safe for humans?
How is time-restricted eating different from other treatments for cancer-related fatigue?
Time-restricted eating (TRE) is unique because it focuses on limiting food intake to specific hours of the day, aligning with the body's natural circadian rhythms, which may help improve energy metabolism and reduce fatigue. Unlike other treatments that might involve medication or supplements, TRE is a dietary approach that leverages the timing of meals to potentially alleviate cancer-related fatigue.25689
Eligibility Criteria
This trial is for cancer survivors who are at least 18 years old, have completed their main treatments between 2 months and 2 years ago, can use a smartphone, speak English, and consent to study procedures. They must feel fatigued (score of 4+ on a scale of 0-10) but not be underweight or have conditions like type 1 diabetes that could complicate the diet intervention.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 12-week time-restricted eating intervention or receive general health education
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Healthy lifestyle education
- Time-restricted eating
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator